Benjamin F. Edwards & Company’s Patterson-UTI PTEN Stock Holding History

Benjamin F. Edwards & Company’s Portfolio PTEN Stock Details PTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-470	Closed	-$5K	–	2225
2023 Q4	$5K	Buy	+470	New	+$5.71K	﹤0.01%	1863
2019 Q1	–	Sell	-112	Closed	-$1K	–	1768
2018 Q4	$1K	Buy	+112	New	+$1.65K	﹤0.01%	1654

Other funds holding PTEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Benjamin F. Edwards & Company's PTEN Position: Q1 2024 in Review

Benjamin F. Edwards & Company sold out of Patterson-UTI (PTEN) in Q1 2024, closing a stake of 470 shares — an estimated $5K sold.

Benjamin F. Edwards & Company first reported a position in PTEN in Q4 2018 and held it in 2 quarters. The position peaked at $5K in Q4 2023. 368 funds tracked by Wall St. Rank hold PTEN as of Q1 2024.

Benjamin F. Edwards & Company reported no remaining Patterson-UTI position as of Q1 2024 after selling out during the quarter.
Benjamin F. Edwards & Company sold 470 Patterson-UTI shares in Q1 2024, an estimated $5K.
Benjamin F. Edwards & Company first reported a position in Patterson-UTI in Q4 2018 and held it in 2 quarters.
Benjamin F. Edwards & Company's Patterson-UTI position peaked at $5K in Q4 2023.
368 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q1 2024, filed 29 Apr 2024.